2008
DOI: 10.1073/pnas.0801711105
|View full text |Cite
|
Sign up to set email alerts
|

Structures of synthetic O-antigen fragments from serotype 2aShigella flexneriin complex with a protective monoclonal antibody

Abstract: The anti-LPS IgG mAb F22-4, raised against Shigella flexneri serotype 2a bacteria, protects against homologous, but not heterologous, challenge in an experimental animal model. We report the crystal structures of complexes formed between Fab F22-4 and two synthetic oligosaccharides, a decasaccharide and a pentadecasaccharide that were previously shown to be both immunogenic and antigenic mimics of the S. flexneri serotype 2a O-antigen. F22-4 binds to an epitope contained within two consecutive 2a serotype pent… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

4
62
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 74 publications
(66 citation statements)
references
References 33 publications
(43 reference statements)
4
62
0
Order By: Relevance
“…5 Besides, AB(E)CD, [AB(E)CD] 2 , and [AB(E)CD] 3 were similarly recognized by human sera from patients naturally infected with SF2a, demonstrating that O-Ag epitopes recognized by human sera are, to some extent, present in haptens corresponding to a small number of RUs. In addition, available structural data on [AB(E)CD] 2 and [AB(E)CD] 3 , in complex with one of the available protective mAbs, mIgG F22-4, demonstrated that the nine residue-epitopes that bind to mIgG F22-4 Fab are already present in the decasaccharide (35). As an opening to challenge the topic, additional structural and physicochemical investigations are in progress to unravel the molecular basis for accurate mimicking of SF2a O-SP by [AB(E)CD] 3 .…”
Section: Discussionmentioning
confidence: 99%
“…5 Besides, AB(E)CD, [AB(E)CD] 2 , and [AB(E)CD] 3 were similarly recognized by human sera from patients naturally infected with SF2a, demonstrating that O-Ag epitopes recognized by human sera are, to some extent, present in haptens corresponding to a small number of RUs. In addition, available structural data on [AB(E)CD] 2 and [AB(E)CD] 3 , in complex with one of the available protective mAbs, mIgG F22-4, demonstrated that the nine residue-epitopes that bind to mIgG F22-4 Fab are already present in the decasaccharide (35). As an opening to challenge the topic, additional structural and physicochemical investigations are in progress to unravel the molecular basis for accurate mimicking of SF2a O-SP by [AB(E)CD] 3 .…”
Section: Discussionmentioning
confidence: 99%
“…17,18 Virulence of S. flexneri is intimately linked to this specific and dynamic O-antigen composition. 8,19 The basic unbranched serogroup Y antigen is composed of tetrasaccharide repeat units (RU) with the structure…”
Section: Introductionmentioning
confidence: 99%
“…Minimal epitopes can be composed of short, defined glycans comprising 2-3 monosaccharides, as for the β-(1→2) mannans of the Candida albicans cell wall (4), Vibrio cholerae O1 (5), Shigella flexneri variant Y (6), and Salmonella (7) O-antigens, or a tetrasaccharide, as for the repeating unit (RU) of S. pneumoniae type 14 PS (Pn14) (8,9), and even six sugar residues, as in the case of S. flexneri serotype 2a O-antigen (10). In contrast, the type III PS of Streptococcus agalactiae (group B Streptococcus, GBS) has been proposed as a prototype of a unique length-dependent conformational epitope (11).…”
mentioning
confidence: 99%